The role of nox-mediated oxidation in the regulation of cytoskeletal dynamics

Current Pharmaceutical Design

Volumn 21, Issue 41, 2015, Pages 6009-6022

  Valdivia, Alejandra ^a   Duran, Charity ^a   San Martin, Alejandra ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytoskeleton; NADPH oxidase; Oxidation; ROS; Signaling

Indexed keywords

CORTACTIN; FOCAL ADHESION KINASE; GUANOSINE TRIPHOSPHATASE; HISTONE DEACETYLASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ACTIN FILAMENT; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME METABOLISM; HUMAN; INTERMEDIATE FILAMENT; MICROTUBULE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; CYTOSKELETON; METABOLISM; OXIDATION REDUCTION REACTION;

CYTOSKELETON; HUMANS; NADPH OXIDASE; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84957573638     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666151029112624     Document Type: Review

References (222)

1. Go YM, Jones DP. The redox proteome. J Biol Chem 2013; 288: 26512-20.
2. Zafari AM, Ushio-Fukai M, Akers M, et al. Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998; 32: 488-95.
3. Rajagopalan S, Kurz S, Münzel T, et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916-23.
4. Mohazzab KM, Wolin MS. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am J Physiol 1994; 267: L815-22.
5. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141-8
6. Lassegue B, San Martin A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 2012; 110: 1364-90.
7. Rajagopalan S, Kurz S, Munzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Investig 1996; 97: 1916-23.
8. Tummala PE, Chen XL, Sundell CL, et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999; 100: 1223-9.
9. Wang HD, Pagano PJ, Du Y, et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 1998; 82: 810-8.
10. Wang HD, Xu S, Johns DG, et al. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice.[see comment]. Circ Res 2001; 88: 947-53.
11. Lassegue B, Sorescu D, Szocs K, et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001; 88: 888-94.
12. Maheswaranathan M, Gole HK, Fernandez I, et al. Platelet-derived growth factor (PDGF) regulates Slingshot phosphatase activity via Nox1-dependent auto-dephosphorylation of serine 834 in vascular smooth muscle cells. J Biol Chem 2011; 286: 35430-7.
13. Lee MY, San Martin A, Mehta PK, et al. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2009; 29: 480-7.
14. 2. Am J Physiol Cell Physiol 2009; 296: C711-23.
15. Mouche S, Mkaddem SB, Wang W, et al. Reduced expression of the NADPH oxidase NOX4 is a hallmark of adipocyte differentiation. Biochim Biophys Acta 2007; 1773: 1015-27.
16. Li J, Stouffs M, Serrander L, et al. The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation. Mol Biol Cell 2006; 17: 3978-88.
17. Clempus RE, Sorescu D, Dikalova AE, et al. Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol 2007; 27: 42-8.
18. Dang PM, Cross AR, Quinn MT, Babior BM. Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558 II. Proc Natl Acad Sci USA 2002; 99: 4262-5.
19. Babior BM. The respiratory burst oxidase. Curr Opin Hematol 1995; 2: 55-60.
20. Babior BM. The respiratory burst oxidase. Curr Opin Hematol 1995; 2: 55-60.
21. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 2004; 279: 45935-41.
22. Hanna IR, Dikalova A, Hilenski L, Quinn MT, Griendling KK. Nox 1 binds p22phox to form a functional oxidase in vascular smooth muscle cells (VSMCs). Circulation 2002; 106: II-164.
23. Kawahara T, Ritsick D, Cheng G, Lambeth JD. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1-and Nox2-dependent reactive oxygen generation. J Biol Chem 2005; 280: 31859-69.
24. Lassegue B, Sorescu D, Szocs K, et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.[see comment]. Circ Res 2001; 88: 888-94.
25. Martin-Garrido A, Brown DI, Lyle AN, et al. NADPH oxidase 4 mediates TGF-beta-induced smooth muscle alpha-actin via p38MAPK and serum response factor. Free Radic Biol Med 2011; 50: 354-62.
26. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 2008; 45: 1340-51.
27. Lambeth JD. Regulation of the phagocyte respiratory burst oxidase by protein interactions. J Biochem Mol Biol 2000; 33: 427-439.
28. Landmesser U, Cai H, Dikalov S, et al. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002; 40: 511-5.
29. Lavigne MC, Malech HL, Holland SM, Leto TL. Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 2001; 104: 79-84
30. Banfi B, Clark RA, Steger K, Krause KH. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem 2003; 278: 3510-3.
31. Takeya R, Ueno N, Kami K, et al. Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 2003; 278: 25234-46
32. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002; 91: 406-13.
33. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 2006; 18: 69-82.
34. Lyle AN, Deshpande NN, Taniyama Y, et al. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 2009; 105: 249-59.
35. Wientjes FB, Reeves EP, Soskic V, Furthmayr H, Segal AW. The NADPH oxidase components p47(phox) and p40(phox) bind to moesin through their PX domain. Biochem Biophys Res Commun 2001; 289: 382-8.
36. Martinelli R, Kamei M, Sage PT, et al. Release of cellular tension signals self-restorative ventral lamellipodia to heal barrier micro-wounds. J Cell Biol 2013; 201: 449-65.
37. Wu RF, Gu Y, Xu YC, Nwariaku FE, Terada LS. Vascular endothelial growth factor causes translocation of p47phox to membrane ruffles through WAVE1. J Biol Chem 2003; 278: 36830-40.
38. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HH, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 2008; 45(9): 1340-51.
39. Dikalova A, Clempus R, Lassegue B, et al. Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation 2005; 112: 2668-76.
40. Klomsiri C, Rogers LC, Soito L, et al. Endosomal H2O2 production leads to localized cysteine sulfenic acid formation on proteins during lysophosphatidic acid-mediated cell signaling. Free Radic Biol Med 2014; 71: 49-60.
41. Oakley FD, Abbott D, Li Q, Engelhardt JF. Signaling components of redox active endosomes: the redoxosomes. Antioxid Redox Signal 2009; 11: 1313-33.
42. Paulsen CE, Carroll KS. Cysteine-mediated redox signaling: chemistry, biology, and tools for discovery. Chem Rev 2013; 113: 4633-79.
43. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 2005; 25: 6391-403.
44. Mills JE, Whitford PC, Shaffer J, Onuchic JN, Adams JA, Jennings PA. A novel disulfide bond in the SH2 Domain of the C-terminal Src kinase controls catalytic activity. J Mol Biol 2007; 365: 1460-8
45. DalleDonne I, Milzani A, Colombo R. H2O2-treated actin: assembly and polymer interactions with cross-linking proteins. Biophys J 1995; 69: 2710-9
46. Heneberg P, Draber P. Regulation of cys-based protein tyrosine phosphatases via reactive oxygen and nitrogen species in mast cells and basophils. Curr Med Chem 2005; 12: 1859-71.
47. Taddei ML, Parri M, Mello T, et al. Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. Antioxid Redox Signal 2007; 9: 469-81.
48. DalleDonne I, Milzani A, Colombo R. The tert-butyl hydroperoxide-induced oxidation of actin Cys-374 is coupled with structural changes in distant regions of the protein. Biochemistry 1999; 38: 12471-80.
49. Milzani A, DalleDonne I, Colombo R. Prolonged oxidative stress on actin. Arch Biochem Biophys 1997; 339: 267-74.
50. Lassing I, Schmitzberger F, Bjornstedt M, et al. Molecular and structural basis for redox regulation of beta-actin. J Mol Biol 2007; 370: 331-48.
51. Johansson M, Lundberg M. Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary. BMC Biochem 2007; 8: 26.
52. Drewes G, Faulstich H. The enhanced ATPase activity of glutathione-substituted actin provides a quantitative approach to filament stabilization. J Biol Chem 1990; 265: 3017-21.
53. Stournaras C, Drewes G, Blackholm H, Merkler I, Faulstich H. Glutathionyl(cysteine-374) actin forms filaments of low mechanical stability. Biochim Biophys Acta 1990; 1037: 86-91.
54. Prochniewicz E, Lowe DA, Spakowicz DJ, et al. Functional, structural, and chemical changes in myosin associated with hydrogen peroxide treatment of skeletal muscle fibers. Am J Physiol Cell Physiol 2008; 294: C613-C626.
55. Omann GM, Harter JM, Burger JM, Hinshaw DB. H2O2-induced increases in cellular F-actin occur without increases in actin nucleation activity. Arch Biochem Biophys 1994; 308: 407-12.
56. Moldovan L, Moldovan NI, Sohn RH, Parikh SA, Goldschmidt Clermont PJ. Redox changes of cultured endothelial cells and actin dynamics. Circ Res 2000; 86: 549-57.
57. Janke C, Bulinski JC. Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions. Nat Rev Mol Cell Biol 2011; 12: 773-86.
58. Wloga D, Gaertig J. Post-translational modifications of microtubules. J Cell Sci 2010; 123: 3447-55.
59. Huber K, Patel P, Zhang L, et al. 2-[(1-methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation. Mol Cancer Ther 2008; 7: 143-51.
60. Landino LM, Hasan R, McGaw A, et al. Peroxynitrite oxidation of tubulin sulfhydryls inhibits microtubule polymerization. Arch Biochem Biophys 2002; 398: 213-20.
61. Clark HM, Hagedorn TD, Landino LM. Hypothiocyanous acid oxidation of tubulin cysteines inhibits microtubule polymerization. Arch Biochem Biophys 2014; 541: 67-73.
62. Kirchner K, Mandelkow EM. Tubulin domains responsible for assembly of dimers and protofilaments. EMBO J 1985; 4: 2397-402.
63. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 2008; 9: 690-701.
64. Boulter E, Garcia-Mata R, Guilluy C, et al. Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1. Nat Cell Biol 2010; 12: 477-83.
65. Heo J, Campbell SL. Mechanism of redox-mediated guanine nucleotide exchange on redox-active Rho GTPases. J Biol Chem 2005; 280: 31003-10.
66. Aghajanian A, Wittchen ES, Campbell SL, Burridge K. Direct activation of RhoA by reactive oxygen species requires a redoxsensitive motif. PLoS One 2009; 4: e8045.
67. Heo J, Raines KW, Mocanu V, Campbell SL. Redox regulation of RhoA. Biochemistry 2006; 45: 14481-9.
68. Mordovanakis AG, Easter J, Naumova N, et al. Quasimonoenergetic electron beams with relativistic energies and ultrashort duration from laser-solid interactions at 0.5 kHz. Phys Rev Lett 2009; 103: 235001.
69. Matasova LV, Semenikhina AV, Popova TN, et al. Effect of N-[Imino(4-morpholyl)methyl]guanidine on the oxidative status in rats with toxic hepatitis. Bull Exp Biol Med 2009; 148: 619-22.
70. Xu D, Rovira, II, Finkel T. Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev Cell 2002; 2: 251-2.
71. Frijhoff J, Dagnell M, Godfrey R, Ostman A. Regulation of protein tyrosine phosphatase oxidation in cell adhesion and migration. Antioxid Redox Signal 2014; 20: 1994-2010.
72. Maremmani I, Pacini M, Pani PP, et al. Use of street methadone in italian heroin addicts presenting for opioid agonist treatment. J Addict Dis 2009; 28: 382-8.
73. Peremyslova LM, Kostiuchenko VA, Popova I, Safronova NG. Radioecological situation in the Iset riverside settlements. Radiats Biol Radioecol 2009; 49: 714-20.
74. Meng TC, Fukada T, Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 2002; 9: 387-99.
75. Formanovskii AA, Popova IS, Mikhura IV. The total large-scale synthesis of argiopine. Bioorg Khim 2009; 35: 837-44.
76. Chandrasekar I, Goeckeler ZM, Turney SG, et al. Nonmuscle myosin II is a critical regulator of clathrin-mediated endocytosis. Traffic 2014; 15: 418-32.
77. Recuenco MC, Ohmori T, Tanigawa S, et al. Nonmuscle Myosin II Regulates the Morphogenesis of Metanephric Mesenchyme-Derived Immature Nephrons. J Am Soc Nephrol 2015; 26(5): 1081-91.
78. Shutova M, Yang C, Vasiliev JM, Svitkina T. Functions of nonmuscle myosin II in assembly of the cellular contractile system. PLoS One 2012; 7: e40814.
79. Lee MY, Lee SH, Kim YH, et al. Effect of EGF on [3H]-thymidine incorporation and cell cycle regulatory proteins in primary cultured chicken hepatocytes: Involvement of Ca2+/PKC and MAPKs. J Cell Biochem 2006; 99: 1677-87.
80. Conti MA, Adelstein RS. Nonmuscle myosin II moves in new directions. J Cell Sci 2008; 121: 11-8.
81. Morin NA, Oakes PW, Hyun YM, et al. Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration. J Exp Med 2008; 205: 195-205.
82. Fiaschi T, Cozzi G, Chiarugi P. Redox regulation of nonmuscle myosin heavy chain during integrin engagement. J Signal Transduct 2012; 2012: 754964.
83. MacGrath SM, Koleske AJ. Cortactin in cell migration and cancer at a glance. J Cell Sci 2012; 125: 1621-6.
84. Helwani FM, Kovacs EM, Paterson AD, et al. Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization. J Cell Biol 2004; 164: 899-910.
85. Lapetina S, Mader CC, Machida K, Mayer BJ, Koleske AJ. Arg interacts with cortactin to promote adhesion-dependent cell edge protrusion. J Cell Biol 2009; 185: 503-19.
86. Vuori K, Ruoslahti E. Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J Biol Chem 1995; 270: 22259-62.
87. Fan L, Di Ciano-Oliveira C, Weed SA, et al. Actin depolymerization-induced tyrosine phosphorylation of cortactin: the role of Fer kinase. Biochem J 2004; 380: 581-91.
88. Maruyama S, Kurosaki T, Sada K, Yamanashi Y, Yamamoto T, Yamamura H. Physical and functional association of cortactin with Syk in human leukemic cell line K562. J Biol Chem 1996; 271: 6631-5.
89. Boyle SN, Michaud GA, Schweitzer B, Predki PF, Koleske AJ. A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol 2007; 17: 445-51
90. Sangrar W, Gao Y, Scott M, Truesdell P, Greer PA. Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrin-mediated cell adhesion. Mol Cell Biol 2007; 27: 6140-52.
91. Li Y, Liu J, Zhan X. Tyrosine phosphorylation of cortactin is required for H2O2-mediated injury of human endothelial cells. J Biol Chem 2000; 275: 37187-93.
92. Evans JV, Ammer AG, Jett JE, et al. Src binds cortactin through an SH2 domain cystine-mediated linkage. J Cell Sci 2012; 125: 6185-97.
93. Touyz RM, Yao G, Quinn MT, Pagano PJ, Schiffrin EL. p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler Thromb Vasc Biol 2005; 25: 512-8.
94. Patel VB, Wang Z, Fan D, et al. Loss of p47phox subunit enhances susceptibility to biomechanical stress and heart failure because of dysregulation of cortactin and actin filaments. Circ Res 2013; 112: 1542-56.
95. Touyz RM, Yao G, Schiffrin EL. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23: 981-7.
96. Usatyuk PV, Gorshkova IA, He D, et al. Phospholipase D-mediated activation of IQGAP1 through Rac1 regulates hyperoxia-induced p47phox translocation and reactive oxygen species generation in lung endothelial cells. J Biol Chem 2009; 284: 15339-52.
97. Adcock IM. HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 2007; 150: 829-31.
98. Matsushima S, Kuroda J, Ago T, et al. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res 2013; 112: 651-63.
99. Ago T, Liu T, Zhai P, et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 2008; 133: 978-93.
100. Liu Y, Hernandez-Ochoa EO, Randall WR, Schneider MF. NOX2-dependent ROS is required for HDAC5 nuclear efflux and contributes to HDAC4 nuclear efflux during intense repetitive activity of fast skeletal muscle fibers. Am J Physiol Cell Physiol 2012; 303: C334-C347.
101. Haworth RS, Stathopoulou K, Candasamy AJ, Avkiran M. Neuro hormonal regulation of cardiac histone deacetylase 5 nuclear localization by phosphorylation-dependent and phosphorylation-independent mechanisms. Circ Res 2012; 110: 1585-95.
102. Vega RB, Harrison BC, Meadows E, et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 2004; 24: 8374-85
103. Oka S, Ago T, Kitazono T, Zablocki D, Sadoshima J. The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy. J Mol Med (Berl) 2009; 87: 785-91.
104. Monovich L, Vega RB, Meredith E, et al. A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase. FEBS Lett 2010; 584: 631-7
105. Gupta MP, Samant SA, Smith SH, Shroff SG. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. J Biol Chem 2008; 283: 10135-46.
106. Samant SA, Courson DS, Sundaresan NR, et al. HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity. J Biol Chem 2011; 286: 5567-77.
107. Waltregny D, Glenisson W, Tran SL, et al. Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB J 2005; 19: 966-8.
108. Perdiz D, Mackeh R, Pous C, Baillet A. The ins and outs of tubulin acetylation: more than just a post-translational modification? Cell Signal 2011; 23: 763-71.
109. Yan B, Smith JW. Mechanism of integrin activation by disulfide bond reduction. Biochemistry 2001; 40: 8861-7.
110. Yan B, Smith JW. A redox site involved in integrin activation. J Biol Chem 2000; 275: 39964-72.
111. Peerschke EI. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets. Thromb Haemost 1995; 73: 862-7.
112. Pratico D, Iuliano L, Alessandri C, Camastra C, Violi F. Polymorphonuclear leukocyte-derived O2-reactive species activate primed platelets in human whole blood. Am J Physiol 1993; 264: H1582-H1587
113. Iuliano L, Colavita AR, Leo R, Pratico D, Violi F. Oxygen free radicals and platelet activation. Free Radic Biol Med 1997; 22: 999-1006.
114. Levin L, Zelzion E, Nachliel E, Gutman M, Tsfadia Y, Einav Y. A single disulfide bond disruption in the beta3 integrin subunit promotes thiol/disulfide exchange, a molecular dynamics study. PLoS One 2013; 8: e59175.
115. Fang J, Nurden P, North P, et al. C560Rbeta3 caused platelet integrin alphaII b beta3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality. J Thromb Haemost 2013; 11: 1163-71.
116. Laragione T, Bonetto V, Casoni F, et al. Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomics. Proc Natl Acad Sci USA 2003; 100: 14737-41.
117. de Rezende FF, Martins Lima A, Niland S, et al. Integrin alpha7beta1 is a redox-regulated target of hydrogen peroxide in vascular smooth muscle cell adhesion. Free Radic Biol Med 2012; 53: 521-31.
118. Douglass WA, Hyland RH, Buckley CD, et al. The role of the cysteine-rich region of the beta2 integrin subunit in the leukocyte function-associated antigen-1 (LFA-1, alphaLbeta2, CD11a/CD18) heterodimer formation and ligand binding. FEBS Lett 1998; 440: 414-8.
119. Gofer-Dadosh N, Klepfish A, Schmilowitz H, Shaklai M, Lahav J. Affinity modulation in platelet alpha 2 beta 1 following ligand binding. Biochem Biophys Res Commun 1997; 232: 724-7.
120. Werner E, Werb Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J Cell Biol 2002; 158: 357-68.
121. Chiarugi P, Pani G, Giannoni E, et al. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 2003; 161: 933-44.
122. Wu RF, Xu YC, Ma Z, Nwariaku FE, Sarosi GA, Jr., Terada LS. Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol 2005; 171: 893-904.
123. Datla SR, McGrail DJ, Vukelic S, et al. Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization. Am J Physiol Heart Circ Physiol 2014; 307: H945-H957.
124. Honore S, Kovacic H, Pichard V, Briand C, Rognoni JB. Al-pha2beta1-integrin signaling by itself controls G1/S transition in a human adenocarcinoma cell line (Caco-2): implication of NADPH oxidase-dependent production of ROS. Exp Cell Res 2003; 285: 59-71.
125. Sundaresan M, Zu-Xi Y, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995; 270: 296-299.
126. Garrido-Urbani S, Jemelin S, Deffert C, et al. Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARalpha mediated mechanism. PLoS One 2011; 6: e14665.
127. Schroder K, Helmcke I, Palfi K, Krause KH, Busse R, Brandes RP. Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007; 27: 1736-43.
128. Lee MY, San Martin A, Mehta PK, et al. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 2009.
129. Wingler K, Wunsch S, Kreutz R, Rothermund L, Paul M, Schmidt HH. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 2001; 31: 1456-64.
130. Yin CC, Huang KT. H2O2 but not O2-elevated by oxidized LDL enhances human aortic smooth muscle cell proliferation. J Biomed Sci 2007; 14: 245-54.
131. Szöcs K, Lassègue B, Sorescu D, et al. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol 2002; 22: 21-7.
132. Nishio E, Watanabe Y. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol 1997; 121: 665-70.
133. Wang Z, Castresana MR, Newman WH. Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells. Biochem Biophys Res Commun 2001; 285: 669-74.
134. Meng D, Lv DD, Fang J. Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovasc Res 2008; 80(2): 299-308.
135. Haurani MJ, Cifuentes ME, Shepard AD, Pagano PJ. Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension 2008; 52: 143-9.
136. Wang Z, Castresana MR, Newman WH. Reactive oxygen speciessensitive p38 MAPK controls thrombin-induced migration of vascular smooth muscle cells. J Mol Cell Cardiol 2004; 36: 49-56.
137. ten Freyhaus H, Huntgeburth M, Wingler K, et al. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation. Cardiovasc Res 2006; 71: 331-41.
138. Abid MR, Kachra Z, Spokes KC, Aird WC. NADPH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett 2000; 486: 252-6.
139. Small JV, Stradal T, Vignal E, Rottner K. The lamellipodium: where motility begins. Trends Cell Biol 2002; 12: 112-20
140. Nobes CD, Hall A. Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 1995; 23: 456-9.
141. Vallotton P, Small JV. Shifting views on the leading role of the lamellipodium in cell migration: speckle tracking revisited. J Cell Sci 2009; 122: 1955-8.
142. Kaji N, Ohashi K, Shuin M, Niwa R, Uemura T, Mizuno K. Cell cycle-associated changes in Slingshot phosphatase activity and roles in cytokinesis in animal cells. J Biol Chem 2003; 278: 33450-5.
143. San Martin A, Lee MY, Williams HC, Mizuno K, Lassegue B, Griendling KK. Dual regulation of cofilin activity by LIM kinase and Slingshot-1L phosphatase controls platelet-derived growth factor-induced migration of human aortic smooth muscle cells. Circ Res 2008; 102: 432-8.
144. Kim JS, Huang TY, Bokoch GM. Reactive oxygen species regulate a slingshot-cofilin activation pathway. Mol Biol Cell 2009; 20: 2650-60.
145. San Martin A, Lee MY, Griendling KK. Novel Nox1-Mediated Mechanism of SSH1L Activation in VSMC: Role in Cell Migration. Atheroscler Thromb Vasc Biol 2008; 28: e109.
146. Arber S, Barbayannis FA, Hanser H, et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 1998; 393: 805-9.
147. Toshima J, Toshima JY, Amano T, Yang N, Narumiya S, Mizuno K. Cofilin phosphorylation by protein kinase testicular protein kinase 1 and its role in integrin-mediated actin reorganization and focal adhesion formation. Mol Biol Cell 2001; 12: 1131-45.
148. Yang N, Higuchi O, Ohashi K, et al. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 1998; 393: 809-12.
149. Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006; 21: 269-80.
150. Samstag Y, John I, Wabnitz GH. Cofilin: a redox sensitive mediator of actin dynamics during T-cell activation and migration. Immunol Rev 2013; 256: 30-47.
151. Ballestrem C, Hinz B, Imhof BA, Wehrle-Haller B. Marching at the front and dragging behind: differential alphaVbeta3-integrin turnover regulates focal adhesion behavior. J Cell Biol 2001; 155: 1319-32.
152. Carpenter CL. Actin cytoskeleton and cell signaling. Crit Care Med 2000; 28: N94-9.
153. Geiger B, Yamada KM. Molecular architecture and function of matrix adhesions. Cold Spring Harb Perspect Biol 2011; 3(5): a005033.
154. Wozniak MA, Modzelewska K, Kwong L, Keely PJ. Focal adhesion regulation of cell behavior. Biochim Biophys Acta 2004; 1692: 103-19.
155. Hamadi A, Bouali M, Dontenwill M, Stoeckel H, Takeda K, Ronde P. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. J Cell Sci 2005; 118: 4415-25.
156. Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273: 245-8.
157. Chiarugi P, Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 2003; 28: 509-14.
158. Shinohara M, Shang WH, Kubodera M, et al. Nox1 redoxsignaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 2007.
159. Angers-Loustau A, Cote JF, Charest A, et al. Protein tyrosine phosphatase-PEST regulates focal adhesion disassembly, migration, and cytokinesis in fibroblasts. J Cell Biol 1999; 144: 1019-31
160. Garton AJ, Tonks NK. Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST. J Biol Chem 1999; 274: 3811-8.
161. Sastry SK, Lyons PD, Schaller MD, Burridge K. PTP-PEST controls motility through regulation of Rac1. J Cell Sci 2002; 115: 4305-16.
162. Cai L, Makhov AM, Schafer DA, Bear JE. Coronin 1B antagonizes cortactin and remodels Arp2/3-containing actin branches in lamellipodia. Cell 2008; 134: 828-42.
163. Burgstaller G, Gimona M. Actin cytoskeleton remodelling via local inhibition of contractility at discrete microdomains. J Cell Sci 2004; 117: 223-31.
164. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ, Weaver AM. Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol 2005; 15: 1276-85.
165. Minta JO, Yun JJ, Kabiawu O, Jones J. mRNA differential display identification of vascular smooth muscle early response genes regulated by PDGF. Mol Cell Biochem 2006; 281: 63-75.
166. Sieg DJ, Hauck CR, Schlaepfer DD. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 1999; 112 (Pt 16): 2677-91.
167. Zhai J, Lin H, Nie Z, et al. Direct interaction of focal adhesion kinase with p190RhoGEF. J Biol Chem 2003; 278: 24865-73
168. Holinstat M, Knezevic N, Broman M, Samarel AM, Malik AB, Mehta D. Suppression of RhoA activity by focal adhesion kinaseinduced activation of p190RhoGAP: role in regulation of endothelial permeability. J Biol Chem 2006; 281: 2296-305.
169. Chiarugi P, Cirri P, Taddei L, et al. The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. J Biol Chem 2000; 275: 4640-6.
170. Chiarugi P, Taddei ML, Cirri P, et al. Low molecular weight protein-tyrosine phosphatase controls the rate and the strength of NIH-3T3 cells adhesion through its phosphorylation on tyrosine 131 or 132. J Biol Chem 2000; 275: 37619-27.
171. Vepa S, Scribner WM, Parinandi NL, English D, Garcia JG, Natarajan V. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am J Physiol 1999; 277: L150-L158.
172. Basuroy S, Dunagan M, Sheth P, Seth A, Rao RK. Hydrogen peroxide activates focal adhesion kinase and c-Src by a phosphatidylinositol 3 kinase-dependent mechanism and promotes cell migration in Caco-2 cell monolayers. Am J Physiol Gastrointest Liver Physiol 2010; 299: G186-95.
173. Abdelsaid MA, El-Remessy AB. S-glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration. J Cell Sci 2012; 125: 4751-60.
174. Maraldi T, Prata C, Caliceti C, et al. VEGF-induced ROS generation from NAD(P)H oxidases protects human leukemic cells from apoptosis. Int J Oncol 2010; 36: 1581-9.
175. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24: 677-83.
176. Lee CF, Ullevig S, Kim HS, Asmis R. Regulation of monocyte adhesion and migration by Nox4. PLoS One 2013; 8: e66964
177. Fernandez I M-GA, Clempus RE, Seidel-Rogol B, et al. TGF-mediates focal adhesion maturation by a Smad/Nox4-dependent mechanism that involves regulation of Hsp27 and Hic5. Free Radic Biol Med 2013; 65: S157-8.
178. Shibanuma M, Mashimo J, Kuroki T, Nose K. Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem 1994; 269: 26767-74.
179. Nishiya N, Shirai T, Suzuki W, Nose K. Hic-5 interacts with GIT1 with a different binding mode from paxillin. J Biochem 2002; 132: 279-89.
180. Shibanuma M, Mori K, Kim-Kaneyama JR, Nose K. Involvement of FAK and PTP-PEST in the regulation of redox-sensitive nuclear-cytoplasmic shuttling of a LIM protein, Hic-5. Antioxid Redox Signal 2005; 7: 335-47.
181. Ishino K, Kaneyama A, Shibanuma M, Nose K. Specific decrease in the level of Hic-5, a focal adhesion protein, during immortalization of mouse embryonic fibroblasts, and its association with focal adhesion kinase. J Cell Biochem 2000; 76: 411-9.
182. Avraamides C, Bromberg ME, Gaughan JP, Thomas SM, Tsygankov AY, Panetti TS. Hic-5 promotes endothelial cell migration to lysophosphatidic acid. Am J Physiol Heart Circ Physiol 2007; 293: H193-203.
183. Tumbarello DA, Brown MC, Hetey SE, Turner CE. Regulation of paxillin family members during epithelial-mesenchymal transformation: a putative role for paxillin delta. J Cell Sci 2005; 118: 4849-63.
184. Srinivasan R, Forman S, Quinlan RA, Ohanian J, Ohanian V. Regulation of contractility by Hsp27 and Hic-5 in rat mesenteric small arteries. Am J Physiol Heart Circ Physiol 2008; 294: H961-9
185. Hetey SE, Lalonde DP, Turner CE. Tyrosine-phosphorylated Hic-5 inhibits epidermal growth factor-induced lamellipodia formation. Exp Cell Res 2005; 311: 147-56.
186. Tumbarello DA, Turner CE. Hic-5 contributes to epithelial mesenchymal transformation through a RhoA/ROCK-dependent pathway. J Cell Physiol 2007; 211: 736-47.
187. Miron T, Vancompernolle K, Vandekerckhove J, Wilchek M, Geiger B. A 25-kD inhibitor of actin polymerization is a low molecular mass heat shock protein. J Cell Biol 1991; 114: 255-61.
188. Patil SB, Tsunoda Y, Pawar MD, Bitar KN. Translocation and association of ROCK-II with RhoA and HSP27 during contraction of rabbit colon smooth muscle cells. Biochem Biophys Res Commun 2004; 319: 95-102.
189. Patil SB, Pawar MD, Bitar KN. Phosphorylated HSP27 essential for acetylcholine-induced association of RhoA with PKCalpha. Am J Physiol Gastrointest Liver Physiol 2004; 286: G635-G644.
190. Huot J, Houle F, Marceau F, Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 1997; 80: 383-92.
191. Piotrowicz RS, Hickey E, Levin EG. Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration. FASEB J 1998; 12: 1481-90.
192. Tangkijvanich P, Melton AC, Chitapanarux T, Han J, Yee HF. Platelet-derived growth factor-BB and lysophosphatidic acid distinctly regulate hepatic myofibroblast migration through focal adhesion kinase. Exp Cell Res 2002; 281: 140-7.
193. Hedges JC, Dechert MA, Yamboliev IA, et al. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J Biol Chem 1999; 274: 24211-9.
194. Thiele JJ, Hsieh SN, Briviba K, Sies H. Protein oxidation in human stratum corneum: susceptibility of keratins to oxidation in vitro and presence of a keratin oxidation gradient in vivo. J Invest Dermatol 1999; 113: 335-9.
195. Lee SH, Miyamoto K, Goto T, Oe T. Non-invasive proteomic analysis of human skin keratins: screening of methionine oxidation in keratins by mass spectrometry. J Proteomics 2011; 75: 435-49
196. Sattayakhom A, Ittiwat W, Stremmel W, Chamulitrat W. Redox regulation of cytokeratin 18 protein by NADPH oxidase 1 in preneoplastic human epithelial cells. J Cancer Res Clin Oncol 2011; 137: 1669-78.
197. Rogers KR, Morris CJ, Blake DR. Oxidation of thiol in the vimentin cytoskeleton. Biochem J 1991; 275 (Pt 3): 789-91
198. Lii CK, Lin AH, Lee SL, Chen HW, Wang TS. Oxidative modifications of proteins by sodium arsenite in human umbilical vein endothelial cells. Environ Toxicol 2011; 26: 459-71.
199. Pekovic V, Gibbs-Seymour I, Markiewicz E, et al. Conserved cysteine residues in the mammalian lamin A tail are essential for cellular responses to ROS generation. Aging Cell 2011; 10: 1067-79.
200. Janue A, Odena MA, Oliveira E, Olive M, Ferrer I. Desmin is oxidized and nitrated in affected muscles in myotilinopathies and desminopathies. J Neuropathol Exp Neurol 2007; 66: 711-23.
201. Janue A, Olive M, Ferrer I. Oxidative stress in desminopathies and myotilinopathies: a link between oxidative damage and abnormal protein aggregation. Brain Pathol 2007; 17: 377-88.
202. Canton M, Neverova I, Menabo R, Van Eyk J, Di Lisa F. Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. Am J Physiol Heart Circ Physiol 2004; 286: H870-7.
203. Kaneko K, Nakamura A, Yoshida K, Kametani F, Higuchi K, Ikeda S. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic Res 2002; 36: 303-6.
204. Santpere G, Ferrer I. Delineation of early changes in cases with progressive supranuclear palsy-like pathology. Astrocytes in striatum are primary targets of tau phosphorylation and GFAP oxidation. Brain Pathol 2009; 19: 177-87.
205. Smerjac SM, Bizzozero OA. Cytoskeletal protein carbonylation and degradation in experimental autoimmune encephalomyelitis. J Neurochem 2008; 105: 763-72.
206. Choi J, Forster MJ, McDonald SR, Weintraub ST, Carroll CA, Gracy RW. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease. Free Radic Biol Med 2004; 36: 1155-62.
207. Kato Y, Ono S, Kitamoto N, Kettle AJ. Covalent modification of cytoskeletal proteins in neuronal cells by tryptamine-4,5-dione. Redox Biol 2014; 2C: 983-990.
208. Kim NH, Kang JH. Protective effects of histidine dipeptides on the modification of neurofilament-L by the cytochrome c/hydrogen peroxide system. J Biochem Mol Biol 2007; 40: 125-9.
209. Valencia A, Sapp E, Kimm JS, et al. Striatal synaptosomes from Hdh140Q/140Q knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation. J Hunting Dis 2013; 2: 459-75.
210. Kang JH. Salsolinol, a tetrahydroisoquinoline-derived neurotoxin, induces oxidative modification of neurofilament-L protection by histidyl dipeptides. BMB Rep 2012; 45: 114-9.
211. Kim NH, Jeong MS, Choi SY, Hoon Kang J. Oxidative modification of neurofilament-L by the Cu,Zn-superoxide dismutase and hydrogen peroxide system. Biochimie 2004; 86: 553-9.
212. Furukawa A, Kawamoto Y, Chiba Y, et al. Proteomic identification of hippocampal proteins vulnerable to oxidative stress in excitotoxin-induced acute neuronal injury. Neurobiol Dis 2011; 43: 706-14.
213. Gianni D, Taulet N, Zhang H, et al. A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. ACS Chem Biol 2010; 5: 981-93.
214. Shi J, Ross CR, Leto TL, Blecha F. PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. Proc Natl Acad Sci USA 1996; 93: 6014-8.
215. Ohtake T, Fujimoto Y, Ikuta K, et al. Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells. Br J Cancer 1999; 81: 393-403.
216. Kadi A, de Isla N, Moby V, et al. The Nebivolol action on vascular tone is dependent on actin cytoskeleton polymerization and Rho-A activity into ECs and SMCs. Clin Hemorheol Microcirc 2014; 56: 231-46.
217. Yoshida LS, Abe S, Tsunawaki S. Fungal gliotoxin targets the onset of superoxide-generating NADPH oxidase of human neutrophils. Biochem Biophys Res Commun 2000; 268: 716-23.
218. Hagens WI, Beljaars L, Mann DA, et al. Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers. J Pharmacol Exp Ther 2008; 324: 902-10.
219. Pozo M, Izquierdo MC, de Nicolas R, Egido J, Ortiz A, Gonzalez-Cabrero J. Gliotoxin inhibits neointimal hyperplasia after vascular injury in rats. J Vasc Res 2009; 46: 278-89.
220. Toblli JE, Cao G, Giani JF, Munoz MC, Angerosa M, Dominici FP. Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats. J Hypertens 2011; 29: 1613-23
221. Munnamalai V, Weaver CJ, Weisheit CE, et al. Bidirectional interactions between NOX2-type NADPH oxidase and the F-actin cytoskeleton in neuronal growth cones. J Neurochem 2014; 130: 526-40.
222. Rehman AU, Dugic E, Benham C, Lione L, Mackenzie LS. Selective inhibition of NADPH oxidase reverses the over contraction of diabetic rat aorta. Redox Biol 2013; 2C: 61-64.